ABCC1 and breast cancer: In addition, miRNA-298 effectively targeted ABCC1, enhancing the sensitivity to DOX, whereas miRNA-328 and miRNA-487a amplified breast cancer cells’ sensitivity to mitoxantrone (MX) by directly targeting ABCG2 [96].